Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Manitoba Harvest Partners With Select Nutrition to Gain Greater National Distribution
Company has entered an agreement with Select Nutrition Distributors to distribute their hemp food products throughout the U.S.
- Manitoba Harvest Partners With Select Nutrition to Gain Greater National Distribution
Company has entered an agreement with Select Nutrition Distributors to distribute their hemp food products throughout the U.S.
- MGPI Announces Fiscal 2005 Second Quarter Results
Company reports net income for the quarter was $1,354,000 for tthe quarter compared to $1,834,000 prior year, on sales of $61,164,000 versus $59,409,000 previous year, second quarter.
- MGPI Announces Fiscal 2005 Second Quarter Results
Company reports net income for the quarter was $1,354,000 for tthe quarter compared to $1,834,000 prior year, on sales of $61,164,000 versus $59,409,000 previous year, second quarter.
- Former Heinz North America CEO Joins Atkins Nutritionals As Chairman of the Board and Chief Executive Officer
Company announces that Neil Harrison has joined the company as Chairman of the Board and Chief Executive Officer, Mark Rodriguez, currently General Manager, ANI North America, assumes the position of President of ANI, North America.
- Former Heinz North America CEO Joins Atkins Nutritionals As Chairman of the Board and Chief Executive Officer
Company announces that Neil Harrison has joined the company as Chairman of the Board and Chief Executive Officer, Mark Rodriguez, currently General Manager, ANI North America, assumes the position of President of ANI, North America.
- Former Heinz North America CEO Joins Atkins Nutritionals As Chairman of the Board and Chief Executive Officer
Company announces that Neil Harrison has joined the company as Chairman of the Board and Chief Executive Officer, Mark Rodriguez, currently General Manager, ANI North America, assumes the position of President of ANI, North America.
- Former Heinz North America CEO Joins Atkins Nutritionals As Chairman of the Board and Chief Executive Officer
Company announces that Neil Harrison has joined the company as Chairman of the Board and Chief Executive Officer, Mark Rodriguez, currently General Manager, ANI North America, assumes the position of President of ANI, North America.
- Nu Skin Enterprises Reports Record Fourth Quarter and Year-End Revenue
Company reports revenue of $1.14 billion for 2004, and for the fourth quarter, revenue of $306.3 million, up 11%. In the quarter, North American revenue grew 13%, South Asia/Pacific was even, Greater China rose 44%, North Asia rose 2%, and other markets grew 34%. Fourth quarter overall operating margin was 10.9 percent.
- Nu Skin Enterprises Reports Record Fourth Quarter and Year-End Revenue
Company reports revenue of $1.14 billion for 2004, and for the fourth quarter, revenue of $306.3 million, up 11%. In the quarter, North American revenue grew 13%, South Asia/Pacific was even, Greater China rose 44%, North Asia rose 2%, and other markets grew 34%. Fourth quarter overall operating margin was 10.9 percent.
- Life-science-man Invests in Food Safety and Health
Finnish companies Life-science-man Ltd., and Medikalla Group, have signed a letter of intent under which Life-science-man Ltd and Mediakalla's FoodFiles Ltd. will merge to form an international service center for the food, pharma and chemical industries.
- Life-science-man Invests in Food Safety and Health
Finnish companies Life-science-man Ltd., and Medikalla Group, have signed a letter of intent under which Life-science-man Ltd and Mediakalla's FoodFiles Ltd. will merge to form an international service center for the food, pharma and chemical industries.
- Life-science-man Invests in Food Safety and Health
Finnish companies Life-science-man Ltd., and Medikalla Group, have signed a letter of intent under which Life-science-man Ltd and Mediakalla's FoodFiles Ltd. will merge to form an international service center for the food, pharma and chemical industries.
- Life-science-man Invests in Food Safety and Health
Finnish companies Life-science-man Ltd., and Medikalla Group, have signed a letter of intent under which Life-science-man Ltd and Mediakalla's FoodFiles Ltd. will merge to form an international service center for the food, pharma and chemical industries.
- Life-science-man Invests in Food Safety and Health
Finnish companies Life-science-man Ltd., and Medikalla Group, have signed a letter of intent under which Life-science-man Ltd and Mediakalla's FoodFiles Ltd. will merge to form an international service center for the food, pharma and chemical industries.
- The Solae Company Unveils New Corporate Tagline
New tagline is "Better Ingredients for Better Living(TM)".
- The Solae Company Unveils New Corporate Tagline
New tagline is "Better Ingredients for Better Living(TM)".
- USANA Announces Fourth Quarter and Annual Results
Company reports sales for the fourth quarter of $75.1 million, compared with $59.5 million prior year; earnings per share were $0.46, compared with $0.32 in the fourth quarter of 2003.
- USANA Announces Fourth Quarter and Annual Results
Company reports sales for the fourth quarter of $75.1 million, compared with $59.5 million prior year; earnings per share were $0.46, compared with $0.32 in the fourth quarter of 2003.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Natural Alternatives International, Inc. Reports Second Quarter Results
Company reports net sales of $21.5 million, up from $17.2 million prior year, with growth resulting from a 33% increase in contract manufacturing sales; Income before income taxes increased 68% to $1.0 million from $612,000 in the comparable quarter last year.
- Natural Alternatives International, Inc. Reports Second Quarter Results
Company reports net sales of $21.5 million, up from $17.2 million prior year, with growth resulting from a 33% increase in contract manufacturing sales; Income before income taxes increased 68% to $1.0 million from $612,000 in the comparable quarter last year.
- Federal Court Order Finds Kemin’s two U. S. Lutein Patents Valid and Enforceable
order, filed this week in the U.S. District Court for the Southern District of Iowa holds that the two contested patents [U.S. Patents 5,382,714 (‘714) and 5,648,564 (‘564)] are both valid and enforceable.
- Federal Court Order Finds Kemin’s two U. S. Lutein Patents Valid and Enforceable
order, filed this week in the U.S. District Court for the Southern District of Iowa holds that the two contested patents [U.S. Patents 5,382,714 (‘714) and 5,648,564 (‘564)] are both valid and enforceable.
- Dean Foods Company Reports Fourth Quarter and Full Year Results
Company reports that adjusted net income for the fourth quarter grew 10% to $98.8 million compared with $89.9 million in the fourth quarter of 2003; company earned $0.64 per diluted share compared to $0.54 per share prior year.
- Dean Foods Company Reports Fourth Quarter and Full Year Results
Company reports that adjusted net income for the fourth quarter grew 10% to $98.8 million compared with $89.9 million in the fourth quarter of 2003; company earned $0.64 per diluted share compared to $0.54 per share prior year.
- Fytokem Announces New Board Members
Company announces that John Cross and Roger Francis, have accepted appointments to the board of directors.
- Fytokem Announces New Board Members
Company announces that John Cross and Roger Francis, have accepted appointments to the board of directors.
- Fytokem Announces New Board Members
Company announces that John Cross and Roger Francis, have accepted appointments to the board of directors.
- Fytokem Announces New Board Members
Company announces that John Cross and Roger Francis, have accepted appointments to the board of directors.
- Two new Directors join GROUPE DANONE Board
The Board of Directors of Groupe Danone has co-opted Mr. Jean Laurent to the position of independent Director and will put a proposal to the next General Meeting of Shareholders for the appointment of Mr. Bernard Hours as a Director.
- Two new Directors join GROUPE DANONE Board
The Board of Directors of Groupe Danone has co-opted Mr. Jean Laurent to the position of independent Director and will put a proposal to the next General Meeting of Shareholders for the appointment of Mr. Bernard Hours as a Director.
- Two new Directors join GROUPE DANONE Board
The Board of Directors of Groupe Danone has co-opted Mr. Jean Laurent to the position of independent Director and will put a proposal to the next General Meeting of Shareholders for the appointment of Mr. Bernard Hours as a Director.
- Two new Directors join GROUPE DANONE Board
The Board of Directors of Groupe Danone has co-opted Mr. Jean Laurent to the position of independent Director and will put a proposal to the next General Meeting of Shareholders for the appointment of Mr. Bernard Hours as a Director.
- Nutrition 21 Reports Second Quarter Results
Company reports revenues of $3.7 million compared to $2.3 million for the same period last year, with a net loss that narrowed to $0.3 million, or ($0.01) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share prior year.
- Nutrition 21 Reports Second Quarter Results
Company reports revenues of $3.7 million compared to $2.3 million for the same period last year, with a net loss that narrowed to $0.3 million, or ($0.01) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share prior year.
- Galaxy Nutritional Foods Reports Third Quarter Operating Results
Company reports sales increased 10% to approximately $10.6 million, compared with approximately $9.6 million prior year, and reports a net operating loss of ($450,845) in the third quarter of FY2005, versus a net operating loss of ($1,124,420) previous year, cites high costs as reason for shrinking margin.
- Galaxy Nutritional Foods Reports Third Quarter Operating Results
Company reports sales increased 10% to approximately $10.6 million, compared with approximately $9.6 million prior year, and reports a net operating loss of ($450,845) in the third quarter of FY2005, versus a net operating loss of ($1,124,420) previous year, cites high costs as reason for shrinking margin.
- Brand New Brands, Inc. Launched to Develop 'Functional' Foods & Beverages; Announces $15 Million in Funding
Brand New Brands has raised $15 million in venture capital from Burrill & Company, Great Spirit Ventures, Unilever Ventures and Prolog Ventures; three co-founders include Greg Horn, Pete Mattson, and William Rosenzweig, with the latter to serve as CEO.
- Brand New Brands, Inc. Launched to Develop 'Functional' Foods & Beverages; Announces $15 Million in Funding
Brand New Brands has raised $15 million in venture capital from Burrill & Company, Great Spirit Ventures, Unilever Ventures and Prolog Ventures; three co-founders include Greg Horn, Pete Mattson, and William Rosenzweig, with the latter to serve as CEO.
- Brand New Brands, Inc. Launched to Develop 'Functional' Foods & Beverages; Announces $15 Million in Funding
Brand New Brands has raised $15 million in venture capital from Burrill & Company, Great Spirit Ventures, Unilever Ventures and Prolog Ventures; three co-founders include Greg Horn, Pete Mattson, and William Rosenzweig, with the latter to serve as CEO.
- Natural Health Trends Corp. Appoints Keith C. Zagar Chief Operating Officer and General Counsel
Zagar comes to company from Guild Electrical & Telecom Services.
- Natural Health Trends Corp. Appoints Keith C. Zagar Chief Operating Officer and General Counsel
Zagar comes to company from Guild Electrical & Telecom Services.
- Natural Health Trends Corp. Appoints Keith C. Zagar Chief Operating Officer and General Counsel
Zagar comes to company from Guild Electrical & Telecom Services.
- Natural Health Trends Corp. Appoints Keith C. Zagar Chief Operating Officer and General Counsel
Zagar comes to company from Guild Electrical & Telecom Services.
- Advanced Nutraceuticals Announces First Quarter Results and Estimated 2005 Sales
Company reports quarterly sales of $4.5 million compared to $4.1 million prior year and net income of of $635,000 versus $604,000 the previous year.
- Advanced Nutraceuticals Announces First Quarter Results and Estimated 2005 Sales
Company reports quarterly sales of $4.5 million compared to $4.1 million prior year and net income of of $635,000 versus $604,000 the previous year.
- Nature's Sunshine Reports 2004 Revenues
Company reports sales revenue of $331.1 million, compared with $260.2 million prior year; Q4 revenues were $88.3 million, compared with $68.8 previous year, with operating income of $6.5 million, compared with $3.8 million for the same quarter last year.
- Nature's Sunshine Reports 2004 Revenues
Company reports sales revenue of $331.1 million, compared with $260.2 million prior year; Q4 revenues were $88.3 million, compared with $68.8 previous year, with operating income of $6.5 million, compared with $3.8 million for the same quarter last year.
- Balchem Corporation Announces 4th Quarter Earnings Results
Company reports sales of $18.0 million for Q4, compared to $16.4 million prior year; net earnings were $2.0 million, an increase of $.7 million over previous year. Sales of the Encapsulated/Nutritional Products segment were $6.2 million in the period, an increase of 2.2% over prior year.
- Balchem Corporation Announces 4th Quarter Earnings Results
Company reports sales of $18.0 million for Q4, compared to $16.4 million prior year; net earnings were $2.0 million, an increase of $.7 million over previous year. Sales of the Encapsulated/Nutritional Products segment were $6.2 million in the period, an increase of 2.2% over prior year.
- MEG-3(TM) Healthy Food Ingredient - US Production Expansion Announced
Capacity expands with purchase of an existing facility in Arcadia, Wisconsin.
- MEG-3(TM) Healthy Food Ingredient - US Production Expansion Announced
Capacity expands with purchase of an existing facility in Arcadia, Wisconsin.
- MEG-3(TM) Healthy Food Ingredient - US Production Expansion Announced
Capacity expands with purchase of an existing facility in Arcadia, Wisconsin.
- MEG-3(TM) Healthy Food Ingredient - US Production Expansion Announced
Capacity expands with purchase of an existing facility in Arcadia, Wisconsin.
- DSM: Solid Improvement in 2004 and Positive Perspectives for 2005
Company rports 8% organic growth year over year; DSM Nutritionals sales stable with newly launched products accounting for 10% of overall sales, while sales and operating profit were adversely affected by exchange rate of dollar.
- DSM: Solid Improvement in 2004 and Positive Perspectives for 2005
Company rports 8% organic growth year over year; DSM Nutritionals sales stable with newly launched products accounting for 10% of overall sales, while sales and operating profit were adversely affected by exchange rate of dollar.
- Novogen Patent License to Solae Now Transferred to ADM
The license covering Novogen patent rights to soy isoflavones, previously with Solae LLC, has now been transferred to Archer Daniels Midland Company (ADM).
- Novogen Patent License to Solae Now Transferred to ADM
The license covering Novogen patent rights to soy isoflavones, previously with Solae LLC, has now been transferred to Archer Daniels Midland Company (ADM).
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
|
AUSTIN, Texas, Feb 09, 2005 /PRNewswire-FirstCall via COMTEX/ -- Whole Foods Market, Inc. (WFMI) today reported sales and earnings for the 16-week quarter ended January 16, 2005. For the quarter, sales increased 22% to $1.37 billion. This increase was driven by 15% weighted average year-over-year square footage growth and comparable store sales growth of 11.4%. Sales in identical stores (excluding one relocated store and two major store expansions) increased 10.7% for the quarter. Net income increased 27% to $49.1 million, diluted earnings per share increased 21% to $0.73, and Economic Value Added (EVA) improved $3.3 million to $6.9 million.
"I would like to appreciate all of our Team Members for their hard work and all of our customers for their continued support. Sales grew by 22% on top of a 21% increase last year and we produced 21% EPS growth on top of a 43% increase last year," said John Mackey, Chairman, Chief Executive Officer, and Co-Founder of Whole Foods Market. "We are very pleased with our performance this quarter, particularly in light of our difficult year-over-year comparisons; however as we have previously stated, we do not expect to see this same level of year over year increases in sales and earnings to continue throughout the year. We continue to expect comparable store sales increases for the year of 8% to 10% and for diluted earnings per share growth to be lower than sales growth primarily due to the anticipated acceleration in new store openings."
In the quarter, gross profit increased 18 basis points to 34.7% of sales, which was offset by a 19 basis point increase in direct store expenses to 25.4% of sales, resulting in store contribution of 9.2% of sales. For the 145 stores in the comparable store base, gross profit improved 66 basis points to 35.1% of sales, and direct store expenses improved 16 basis points to 25.1% of sales, resulting in an 82 basis point increase in store contribution to 10.1% of sales. General and administrative (G&A) expenses improved 25 basis points to 3.0% of sales.
Capital expenditures in the quarter were $85 million of which $56 million was for new store development. During the quarter, the Company produced cash flow from operations of $122 million and paid approximately $9 million to shareholders in quarterly dividends. Cash and cash equivalents, including restricted cash, were approximately $261 million at the end of the quarter, and total long-term debt was approximately $101 million. During the quarter, approximately 137,000 of the Company's Zero Coupon Convertible Debentures were voluntarily converted by bondholders to approximately 1.5 million shares of common stock resulting in a decrease in the Zero Coupon Convertible Debt from $159 million at the end of last fiscal year to $89 million at the end of the first quarter.
In November, the Company announced that its Board of Directors approved a 27% increase in the Company's quarterly dividend. On January 17, 2005, the Company paid approximately $12 million to shareholders in quarterly dividends of $0.19 per share.
In the quarter, the Company opened three new stores in Hingham, MA; Redwood City, CA and Sarasota, FL, ending the quarter with 166 stores totaling approximately 5.3 million square feet. The Company is pleased to announce the recent signing of 7 new store leases in Lake Oswego, OR; Seattle, WA; Novato, CA; Scottsdale, AZ; Pasadena, CA; Annapolis, MD (relocation) and Rockville, MD (relocation).
The Company has a stated long-term growth goal of $10 billion in sales by the year 2010. As shown in the table below, the Company produced above- average sales and comparable store sales increases in fiscal year 2004 and will, therefore, face difficult comparisons in 2005, particularly in the second quarter when it will be comparing against a 17.1% comparable store sales increase and a 32% increase in diluted EPS.
For the fiscal year, the Company continues to expect sales growth of 15% to 20% driven by comparable store sales growth of 8% to 10% and weighted average square footage growth of approximately 15% based on the opening of 15 to 18 new stores, including four relocations. The Company does not expect the same level of year over year increases in sales and earnings produced in the first quarter to continue throughout the year. The Company continues to expect diluted earnings per share growth for the year to be lower than sales growth primarily due to the anticipated acceleration in new store openings, which is expected to result in pre-opening expenses in the range of $18 million to $20 million versus $10 million in the prior year. In addition, new stores could have some negative impact on store contribution, as new stores generally have lower gross margins and higher direct store expenses than more mature stores. The Company also expects G&A expenses for the remainder of the fiscal year to be higher as a percentage of sales as compared to the first quarter and as compared to the prior year, primarily due to the relocation of the Company's headquarters in January which is expected to add approximately $4 million in G&A expenses annually. Capital expenditures are still expected to be in the range of $300 million to $320 million.
In December the Financial Accounting Standards Board (FASB) finalized Statement 123R, Share-based Payment, which requires all companies to expense share-based payments, including stock options, at fair value. Absent any overruling by Congress, the new rules are effective for interim or annual periods beginning after June 15, 2005; therefore, the Company would expect to begin expensing stock options in the fourth quarter of fiscal year 2005.
Though not retroactive, it should be noted that the charge to earnings resulting from this new rule includes the impact of stock options granted in prior years, since the expense is recognized over the vesting period of the options, which for the Company has been four years. Even if the Company never granted another option after today, it would still have stock option expense until all past option grants were fully vested. In order to prevent this "overhang" from past option grants impacting future income statements, the Company is today announcing its intention, absent FASB 123R being overruled by Congress, to accelerate the vesting of all outstanding stock options (excluding options held by the Board of Directors and the members of the executive team) sometime prior to July 4, 2005, the date the new rules are effective for the Company. This accelerated vesting of options will create a one-time, mostly non-cash charge in the third fiscal quarter of this year of approximately $10 million, consisting of the estimated increase in value to the option holders caused by the acceleration plus accrual of certain payroll taxes that will be due upon exercise of the options. The actual amount of the expense will vary based on the closing stock price at the date of the acceleration.
The Company's current intention is to keep its broad-based stock option program in place, but going forward it will limit the number of shares granted in any one year so that net income dilution from equity-based compensation expense (EBCE) will not exceed 10% in future years. The EBCE will ramp up beginning in the fourth quarter of fiscal year 2005 until it reaches 10% of net income in fiscal year 2010. EBCE in the fourth quarter of fiscal year 2005 is expected to be approximately $500,000 consisting primarily of grants to the executive team and the Board of Directors, since the Company will not accelerate those options. This estimated expense does not impact the Company's annual guidance.
The Company believes this strategy is best aligned with its stakeholder philosophy because it limits future earnings dilution from options while at the same time retains the broad-based stock option plan which it believes is important to Team Member morale and to its unique corporate culture and its success.
About Whole Foods Market: Founded in 1980 in Austin, Texas, Whole Foods Market(R) is the largest natural and organic foods retailer. The Company had sales of $3.9 billion in fiscal year 2004 and currently has 166 stores in the United States, Canada and the United Kingdom.
The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, which could cause our actual results to differ materially from those described in the forward looking statements. These risks include but are not limited to general business conditions, the timely development and opening of new stores, the integration of acquired stores, the impact of competition, and other risks detailed from time to time in the Company's SEC reports, including the report on Form 10K for the fiscal year ended September 26, 2004. The Company does not undertake any obligation to update forward-looking statements.
|